Before the Bell
$
3.54
Change
-0.05 -1.39%
Volume
Volume 5,916
Jan 28, 2021, 8:58 a.m.
Real time quotes
Previous close
$ 3.59
$ 3.59
Change
+0.04 +0.98%
Day low
Day high
$3.41
$3.65

52 week low
52 week high
$2.55
$7.45

Market cap
$104.66M
Average volume
1.09M
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-2.08
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ZYNE
-
Tech rally leads stocks higher; trade and Fed minutes also in focus
- Barbara Kollmeyer
-
Zynerba says it now has enough cash to last until second half of 2019
- Ciara Linnane
-
Zynerba shares slide 4.6% premarket
- Ciara Linnane
-
Zynerba Pharma says study of cannabinoid skin patch did not meet goals
- Ciara Linnane
-
Zynerba will now focus efforts on epilepsy program
- Ciara Linnane
-
Zynerba Pharmaceuticals downgraded to perform from outperform at Oppenheimer
- Tomi Kilgore
-
Zynerba Pharmaceuticals downgraded to hold from buy at Maxim Group
- Tomi Kilgore
-
GW Pharma shares surge 2.7% after Zynerba Pharma's failed cannabidiol gel trial
- Emma Court
-
Zynerba's stock on track to open at lowest level since June 2016
- Tomi Kilgore
-
Zynerba's stock volume tops 600,000 shares premarket, already above full-day average of 590,000
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For January 29, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For October 2, 2017
- Benzinga.com
Other News on ZYNE
-
Zeroing In On Zynerba Pharmaceuticals
- Seeking Alpha
-
Cannabis In California Will Boom Into A Powerhouse Opportunity
- Seeking Alpha
-
Zynerba Pharmaceuticals (ZYNE) Investor Presentation - Slideshow
- Seeking Alpha
-
Mexico to legalize pot to become world's largest cannabis market
- Seeking Alpha
-
The 20 Most Undervalued Cannabis Stocks
- Seeking Alpha
-
MARA, NXTD, ZYNE and SCYX among midday movers
- Seeking Alpha
-
Needham Maintains a Hold Rating on Zynerba Pharmaceuticals (ZYNE)
- SmarterAnalyst
-
CureVac, Triterras leads premarket losers' pack
- Seeking Alpha
-
Cannabis Stocks Are Hot Again And Here Are Some You Should Buy
- Seeking Alpha
-
- Seeking Alpha
-
Zynerba Pharmaceuticals (ZYNE) Receives a Buy from Canaccord Genuity
- SmarterAnalyst
-
10-Q: ZYNERBA PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Zynerba Pharmaceuticals EPS beats by $0.12
- Seeking Alpha
- Loading more headlines...
Press Releases on ZYNE
-
Shuman, Glenn & Stecker Investigates Zynerba Pharmaceuticals, Inc.
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com